HRT Financial’s Guardant Health GH Stock Holding History

HRT Financial’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,200	Closed	-$441K	–	2703
2022 Q3	$441K	Buy	+8,200	New	+$421K	﹤0.01%	1722

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

HRT Financial's GH Position: Q2 2026 in Review

HRT Financial opened a new position in Guardant Health (GH) in Q2 2026: 703,915 shares worth $106M. The stake represents 0.19% of the portfolio and ranks #84 among its holdings. This is a return to the name: HRT Financial previously reported a position in GH as recently as Q4 2025.

HRT Financial first reported a position in GH in Q4 2020 and has held it in 13 quarters since. 601 funds tracked by Wall St. Rank hold GH as of Q2 2026.

HRT Financial held 703,915 shares of Guardant Health worth $106M as of Q2 2026.
Guardant Health was a new HRT Financial position in Q2 2026.
Guardant Health made up 0.19% of HRT Financial's portfolio in Q2 2026, its #84 holding.
HRT Financial first reported a position in Guardant Health in Q4 2020 and has held it in 13 quarters since.
601 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.